These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 17083569)

  • 1. Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer.
    Akino K; Toyota M; Suzuki H; Imai T; Maruyama R; Kusano M; Nishikawa N; Watanabe Y; Sasaki Y; Abe T; Yamamoto E; Tarasawa I; Sonoda T; Mori M; Imai K; Shinomura Y; Tokino T
    Cancer Sci; 2007 Jan; 98(1):88-95. PubMed ID: 17083569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer.
    Obata T; Toyota M; Satoh A; Sasaki Y; Ogi K; Akino K; Suzuki H; Murai M; Kikuchi T; Mita H; Itoh F; Issa JP; Tokino T; Imai K
    Clin Cancer Res; 2003 Dec; 9(17):6410-8. PubMed ID: 14695142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma.
    Kim MS; Chang X; Yamashita K; Nagpal JK; Baek JH; Wu G; Trink B; Ratovitski EA; Mori M; Sidransky D
    Oncogene; 2008 Jun; 27(25):3624-34. PubMed ID: 18223688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion.
    Kim M; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Norman JC; Caswell PT; Kang GH; Kim SY; Yoo HS; Kim YS
    Carcinogenesis; 2008 Mar; 29(3):629-37. PubMed ID: 18283041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
    Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
    Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale analysis of
    Croes L; Beyens M; Fransen E; Ibrahim J; Vanden Berghe W; Suls A; Peeters M; Pauwels P; Van Camp G; Op de Beeck K
    Clin Epigenetics; 2018; 10():51. PubMed ID: 29682089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of the DFNA5 increases risk of lymph node metastasis in human breast cancer.
    Kim MS; Lebron C; Nagpal JK; Chae YK; Chang X; Huang Y; Chuang T; Yamashita K; Trink B; Ratovitski EA; Califano JA; Sidransky D
    Biochem Biophys Res Commun; 2008 May; 370(1):38-43. PubMed ID: 18346456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of Sox17 gene is useful as a molecular diagnostic application in early gastric cancer.
    Oishi Y; Watanabe Y; Yoshida Y; Sato Y; Hiraishi T; Oikawa R; Maehata T; Suzuki H; Toyota M; Niwa H; Suzuki M; Itoh F
    Tumour Biol; 2012 Apr; 33(2):383-93. PubMed ID: 22161215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of estrogen receptor-alpha expression is associated with hypermethylation near its ATG start codon in gastric cancer cell lines.
    Woo IS; Park MJ; Choi SW; Kim SJ; Lee MA; Kang JH; Hong YS; Lee KS
    Oncol Rep; 2004 Mar; 11(3):617-22. PubMed ID: 14767512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas.
    Wen XZ; Akiyama Y; Baylin SB; Yuasa Y
    Oncogene; 2006 Apr; 25(18):2666-73. PubMed ID: 16314833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of BTB and CNC homology 2 and concerted promoter CpG methylation in gastric cancer.
    Haam K; Kim HJ; Lee KT; Kim JH; Kim M; Kim SY; Noh SM; Song KS; Kim YS
    Cancer Lett; 2014 Sep; 351(2):206-14. PubMed ID: 24858026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation and histone deacetylation associated with silencing of SLC5A8 in gastric cancer.
    Ueno M; Toyota M; Akino K; Suzuki H; Kusano M; Satoh A; Mita H; Sasaki Y; Nojima M; Yanagihara K; Hinoda Y; Tokino T; Imai K
    Tumour Biol; 2004; 25(3):134-40. PubMed ID: 15361710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma.
    Okuda H; Toyota M; Ishida W; Furihata M; Tsuchiya M; Kamada M; Tokino T; Shuin T
    Oncogene; 2006 Mar; 25(12):1733-42. PubMed ID: 16278676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers.
    Jung Y; Park J; Bang YJ; Kim TY
    Lab Invest; 2008 Feb; 88(2):153-60. PubMed ID: 18059362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
    He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
    Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer.
    Murai M; Toyota M; Suzuki H; Satoh A; Sasaki Y; Akino K; Ueno M; Takahashi F; Kusano M; Mita H; Yanagihara K; Endo T; Hinoda Y; Tokino T; Imai K
    Clin Cancer Res; 2005 Feb; 11(3):1021-7. PubMed ID: 15709167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG methylation in exon 1 of transcription factor 4 increases with age in normal gastric mucosa and is associated with gene silencing in intestinal-type gastric cancers.
    Kim SK; Jang HR; Kim JH; Kim M; Noh SM; Song KS; Kang GH; Kim HJ; Kim SY; Yoo HS; Kim YS
    Carcinogenesis; 2008 Aug; 29(8):1623-31. PubMed ID: 18635522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
    Bae SI; Lee HS; Kim SH; Kim WH
    Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of the DFNA5 gene is frequently detected in colorectal cancer.
    Yokomizo K; Harada Y; Kijima K; Shinmura K; Sakata M; Sakuraba K; Kitamura Y; Shirahata A; Goto T; Mizukami H; Saito M; Kigawa G; Nemoto H; Hibi K
    Anticancer Res; 2012 Apr; 32(4):1319-22. PubMed ID: 22493364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer.
    Maruyama R; Akino K; Toyota M; Suzuki H; Imai T; Ohe-Toyota M; Yamamoto E; Nojima M; Fujikane T; Sasaki Y; Yamashita T; Watanabe Y; Hiratsuka H; Hirata K; Itoh F; Imai K; Shinomura Y; Tokino T
    Carcinogenesis; 2008 Jul; 29(7):1312-8. PubMed ID: 18310659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.